This collaboration will develop a new research initiative to improve cancer prevention by using molecular technology to enhance the ability to diagnose and treat patients. To enhance Moffitt’s
The New York Times suggested that Eli Lilly encouraged doctors to use Zyprexa in patients who did not have the condition. Documents containing the details of the marketing
Lucassin will be used to treat patients with type 1 hepatorenal syndrome (HRS), a life-threatening condition characterized by rapid kidney failure in patients with end-stage liver cirrhosis, for
The Department of Health and Human Services (HHS) is under a contract with VaxGen to purchase 75 million doses of its recombinant anthrax vaccine, rPA102, had imposed a
Perrigo will be Dexcel Pharma’s exclusive marketer and distributor of this product for the store brand over-the-counter (OTC) market in the US once the product has been approved
The payment will include equipment and inventory payments and gives ZLB Behring full worldwide rights to CytoGam. CytoGam is an intravenous immune globulin enriched in antibodies against cytomegalovirus
The proposed $34 price reflects a $2 per share increase and Lilly has said that this is its best and final offer. Indianapolis-based Lilly is keen to extend
As part of the collaboration, Exelixis will be fully responsible for the identification and preclinical development of small molecule drug candidates directed against mutually selected targets. Bristol-Myers Squibb
Somaxon believes that the product has potential to become a significant participant in the insomnia market. With the conclusion of this trial, Somaxon has completed six clinical trials
Merck agreed to buy the Bertarelli family’s 64.5% stake in Serono in September 2006. Merck had originally turned its attention to the acquisition of Serono after it lost
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.